Functionalized nanocarrier(s) to image and target fungi infected immune cells

References

• Tomee JF, van der Werf TS. Pulmonary aspergillosis. Neth J Med 2001; 59: 244–258
   PubMedGoogle Scholar
• Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988–1999
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Pizzo PA. Treatment of systemic fungal infections: recent progress and current problems. Eur J Clin Microbiol Infect Dis 1990; 7: 460–475
   Google Scholar
• Vyas SP, Khatri K. Liposome-based drug delivery to alveolar macrophages. Expert Opin Drug Deliv 2007; 4: 95–99
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G, Mehta R, Hopffer R, et al. Treatment and prophylaxis of disseminated infections due to Candida albicans in mice with liposomal encapsulated amphotericin B. J Infect Dis 1983; 147: 939–945
   PubMed Web of Science ®Google Scholar
• Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: delivery systems. Antimicrob Agents Chemother 1990; 34: 381–384
   PubMed Web of Science ®Google Scholar
• De Marie S, Janknegt R, Bakker-Woundenberg IAJM. Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994; 33: 907–916
   PubMedGoogle Scholar
• Janknegt R, De Marie S, Bakker-Woundenberg IAJM, Crommellin DJ. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 1992; 23: 279–291
   PubMed Web of Science ®Google Scholar
• Vyas SP. Macrophage targeting and colloidal drug carriers. Advances in Lipsomal Research, SP Vyas, VK Dixit. CBS Publishers and Distributors, New Delhi 2000; 98–120
   Google Scholar
• Vyas SP, Katare YK, Mishra V, Sihorkar V. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm 2000; 210: 1–14
   PubMed Web of Science ®Google Scholar
• Amselem, S, Friedman, D. Solid fat nanoemulsions. 1997; US Patent 5,662, 932.
   Google Scholar
• Amselem S, Yogev A, Zawoznik E, Friedman D. Emulsomes, a novel drug delivery technology. Proceedings of the International Symposium on Controlled Release of Bioactive Materials. 1994; 21: 1368–1369
   Google Scholar
• Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 1978; 90: 809–815
   PubMed Web of Science ®Google Scholar
• Venkatesan N, Vyas SP. Polysaccharide coated liposomes for oral immunization: development and characterization. Int J Pharm 2000; 203: 169–177
   PubMed Web of Science ®Google Scholar
• Sunamoto J, Gato M, Iida T, . Polymer coated liposomes for drug delivery to target specific organs. Receptor Mediated Targeting of Drugs, G Gregoriadis, J Senior, A Trouet, et al. Plenum Press, NewYork 1985; 359–371
   Google Scholar
• Vyas SP, Quraishi S, Gupta S, Jaganathan KS. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm 2005; 296: 12–25
   PubMed Web of Science ®Google Scholar
• Bogdanov AA, Jr, Klibanov AL, Torchilin VP. Protein immobilization on the surface of liposomes via carbodiimide activation in the presence of N-hydroxysulfosuccinimide. FEBS Lett 1988; 231: 381–384
   PubMed Web of Science ®Google Scholar
• Van Etten EWM, van den Heuvel-de Groot C, Bakker-Wouderberg IAJM. Efficacies of amphotericin Bdesoxycholate (Fungizone), liposomal amphotericin B (Ambisome) and fluconazole in the treatment of systemic candidiasis in immunocompetent and leucopenic mice. J Antimicrob Chemother 1993; 32: 723–729
   PubMed Web of Science ®Google Scholar
• New RRC, Black CDV, Parker JR, Puri A, Scherrhof GL. Liposomes in biological systems. Liposomes: A Practical Approach, RRC New. IRL Press, Oxford 1990; 236–237
   Google Scholar
• Andreopoulos D, Kasi LP, Asimacopoulos PJ, et al. Selective in vitro labeling of white blood cells using 99mTc-labeled liposomes. Nuc Med Biol 2002; 29: 185–190
   PubMedGoogle Scholar
• Farr SJ, Kellaway IW, Parry-Jones DR, Wllfrey SG. 99mTechnetium as a marker of liposomal deposition and clearance in the human lung. Int J Pharm 1985; 26: 303–316
   Web of Science ®Google Scholar
• Lowell GH, Kaminski RW, VanCott TC, et al. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG. J Infect Dis 1997; 175: 292–301
   PubMed Web of Science ®Google Scholar
• Kretschmar M, Amselem S, Zawoznik E, et al. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes). Mycoses 2001; 44: 281–286
   PubMed Web of Science ®Google Scholar
• Jain S, Vyas SP. Mannosylated niosomes as carrier adjuvant system for topical immunization. J Pharm Pharmacol 2005; 57: 1177–1184
   PubMed Web of Science ®Google Scholar